Q1 2026 BICO Group AB Earnings Call Transcript
Key Points
- BICO Group AB (CLLKF) reported 11% organic growth in Q1 2026, indicating a strong start to the year despite challenging market conditions.
- The company successfully issued senior secured bonds of EUR 40 million, enhancing its financial position to support further growth.
- BICO's lab automation solutions have led to significant productivity gains for customers, with some reporting a 75% reduction in process time and a 400% increase in equipment capacity.
- The company is focusing on AI-driven lab automation, which is expected to enhance efficiency and speed in drug discovery processes.
- BICO has a solid R&D pipeline with a focus on software development and AI, positioning it well for future growth and innovation.
- Total reported growth was negative 1.4% due to continued currency headwinds, impacting overall financial performance.
- EBITDA was negative SEK42 million, with adjusted EBITDA at negative SEK11 million, primarily due to restructuring costs.
- The company faced challenges in the US academic market, which remains soft with cautious spending and delayed capital equipment purchases.
- Geopolitical uncertainty and tariffs affected business decisions, particularly in February, impacting sales cycles.
- BICO's lab automation business, particularly Biosero, started off slower in Q1, indicating potential execution challenges in complex projects.
Welcome to BICO Q1 2026 report presentation. (Operator Instructions)
Now I will hand the conference over to the speakers, CEO, Maria Force; and CFO, Ewa Linsater . Please go ahead.
Hello, and welcome to BICO Group's quarter 1 2026 earnings call. I'm Maria Forss, President and CEO, and I will together with BICO's CFO, Ewa Linsater, present this interim report. Here is today's agenda. I will open today's session by summarizing quarter 1 2026 and also describe how BICO serves the world's leading pharma and biotech companies with solutions that transform how labs operate, innovate and solve our customers' challenges.
Following that, Ewa will present the group's financial performance. I will then comment on our R&D pipeline with our ongoing product development efforts. Additionally, I will highlight some recent and upcoming product launches. The session will conclude by highlighting our focus for 2026 before we open up for Q&A. A strong start to the year with 11% organic
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
